Revealing Engagement Patterns Among Hepatic Encephalopathy Patients

This study aims to investigate the influences behind patient choices regarding involvement, discontinuation, or re-engagement in hepatic encephalopathy clinical trials. Uncovering these factors is essential to enhance the relevance and efficacy of future research endeavors.

In essence, this trial aims to deepen understanding of the factors influencing participation in hepatic encephalopathy clinical trials. Elevating participation rates could expedite the development of innovative treatments for this challenging condition.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Hepatic Encephalopathy Brain Diseases Brain Diseases, Metabolic Central Nervous System Diseases Digestive System Diseases Hepatic Insufficiency Liver Diseases Liver Failure Metabolic Diseases Nervous System Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Power Life Sciences

San Francisco, California, 94107, United States

Location contact

Michael B Gill

CONTACT

https://www.withpower.com/[email protected]

415-900-4227

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Signed Written Informed Consent
Aged ≥ 18 years old
No prior treatment for hepatic encephalopathy

Exclusion criteria

Participant is actively receiving study therapy in another
Inability to provide written informed consent
Women of childbearing potential without a negative pregnancy test; or women who are lactating.

Treatment and study plan

Primary outcomes

Rate of patients who decide to join in a hepatic encephalopathy clinical trial

Time frame: 3 months
Number of hepatic encephalopathy patients who remain in clinical trial until completion

Time frame: 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Michael B Gill

CONTACT

[email protected]

(415) 900-4227

Sponsors and collaborators

Lead sponsor

Power Life Sciences Inc.

Industry

Registry information

Official study title

Assessing Patient Engagement and Understanding in Hepatic Encephalopathy Clinical Research

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2027
First posted: Jan 11, 2024
Registry last updated: Feb 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting